CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Login
View profile
Log out
Welcome back

Click below to sign in and see leads, RFIs or statistics

Sign in

Sign out
- Search Impressions
  
  3 287
- Page views
  
  324
- Request for information
  
  54
Subscribe

Single B Cell Screening

Product Description

Biointron offers a high-throughput, fully integrated platform for accelerating antibody discovery. Biointron's high-throughput single B cell screening platform can screen 2*10^6 plasma B-cells from immunized animals. Antigen specific antibody-secreting cells can be isolated. It allows the detection of potentially rare antibodies or drugs with unique properties.

Highlights:

Microfluidic Technology: Microfluidic-based methods can achieve higher throughput and greater flexibility over nanowell and nanovial techniquesThis technology has been used in research with single-cell genetics, epigenetics, transcriptomics, proteomics and metabolism
High Efficiency: NGS sequencing & HTP mammalian Production/Validation;
Short Timeline: Millions of cells can be screened within 1 week. By bypassing conventional hybridoma steps with single B cell screening, you can expect to gain 2-3 months.

Biointron Biological

US
2024

On CPHI since
2

Certificates
500 - 999

Employees

Company types

Contract Research Organisation (CRO)

Primary activities

Contract Research Organisation

Compare Add to favorites Added to favorites

Categories

Specifications

Details

https://www.biointron.com/antibody-discovery/single-b-cell-screening.html

Biointron Biological

US
2024

On CPHI since
2

Certificates
500 - 999

Employees

Company types

Contract Research Organisation (CRO)

Primary activities

Contract Research Organisation

Compare Add to favorites Added to favorites

Frequently Viewed Together

Product Biologics

End-to-end development and manufacturing capabilities across different therapeutic modalities and the entire product lifecycle

Cutting-edge technology platforms for high yielding cell lines (both mammalian and microbial) and high concentration formulations

Integrated and flexible drug sub...
Product Biologic drug substance CDMO services

From pre-clinical development to commercial supply, Patheon by Thermo Fisher Scientific is an industry leader in the development and manufacture of mammalian cell culture drug substances. Patheon offers biotech and pharmaceutical companies the ability to pursue opportunities around the globe with a fully i...
Product Walk in Cooling Cabinet.

The Walk-In Cooling Cabinets / cold rooms are designed according to ICH guidelines, WHO, MCA and USFDA requirements to maintain uniform conditions. They are superior in airflow distribution, temperature control technology, cabinet construction and are manufactured as per cGMP regulations.
Biggest Walk...
Product UV Light Blocking Tyvek Equipment Covers

UV Light Blocking Tyvek Equipment Covers are designed to keep cleaned pharmaceutical equipment and supplies clean and protected from external sources of contamination while also providing in-process protection to light sensitive biotech products.
Product Contract Manufacturing (CDMO/CRO/CMO)

We are world's leading contract manufacturer.
Product 1 GHz NMR

New Evo 1 GHz NMR fits in 1 story building, uses 70% less helium. Ideally suited to characterise complex molecules such as RNA, oligonucleotides, peptides, antibodies and more!
Product CDMO Biopharmaceutical Production

With an extensive offering of development services, state-of-the-art manufacturing equipment, and project support, GBI is truly a full-service CDMO biologics partner. Our approach pairs our expert knowledge base with an open mind towards scientific discovery so that together we can develop an optimal way t...
Product cGMP Cell-based Bioassays

Cell-based bioassays that comply with cGMP: Using a variety of techniques, including cell-based assays, ligand and receptor binding assays, and flexible multiple assay approaches – our potency testing experts offer tailored bioassay method development, method transfer and method validation to ICH Q2 (R1)...
Product HANSIZHUANG (Serplulimab Injection)

HANSIZHUANG (recombinant humanized anti-PD-1 monoclonal antibody injection, generic name: serplulimab injection) is the first anti-PD-1 mAb for the first-line treatment of SCLC and has been approved in China and Indonesia. Up to date, 4 indications are approved for marketing, 2 marketing applications a...
Product Biologic Quality Control and Release Testing

We deliver responsive QC analysis for complex biologic products from our cGMP laboratories. Our scientists develop and validate methods or perform technology transfer of a sponsor's method for a wide range of analytical methods required for batch release testing. We also routinely carry out testing to Phar...
Product Biologics - mAbs, therapeutic proteins and ADC development

Eurofins CDMO Alphora Inc. provides integrated solutions for small molecules, drug product, biologics and phytocannabinoids. Specializing in complex and niche small molecule drug substance and drug product services, including high potent capabilities, we provide support from preclinical to commercial devel...
Product Kemwell Biopharma

SERVICES Kemwell provides integrated development and manufacturing services for companies that require one-stop solution for mammalian cell-culture based protein therapeutics The team is experienced to undertake end-to-end activities right from cell line development till cGMP clinical and commercial manufa...
Product Biosimilars Portfolio

• Pegfilgrastim (Filed with EMA) • Filgrastim (Filed with EMA) • Trastuzumab (Filed with EMA, MHRA, Received recommendation for marketing authorization in India) • Bevacizumab (Filed with MHRA) • Omalizumab (Global PhIII ongoing) • Denosumab (Global PhIII ongoing) • Ranibizumab (Global PhIII ongoing...
Product HANLIKANG (Rituximab Injection)

HANLIKANG (rituximab injection) is the company's first proprietary product. It is the first-ever China-manufactured biosimilar approved by the NMPA in accordance with the Technical Guideline for the Development and Evaluation of Biosimilars (Tentative) issued in 2015. As of now, HANLIKANG has bee...
Product Fermenters

Fermentation is mostly extracellular activity and is brought with the help of enzymes released by the microorganisms. The Fermenter is designed to meet all process requirement for micro-organism to achieve maximum growth and productivity. Features:
• Fully automated or semi-automated models
• 21...
Product Bevacizumab

Bevacizumab acts by selectively binding circulating VEGF, thereby inhibiting the binding of VEGF to its cell surface receptors. This inhibition leads to a reduction in microvascular growth of tumor blood vessels that limits the blood supply to tumor tissues.The indication is for Colorectal Cancer...
Product Epicyn

Epicyn™ with patented technology is intended for the management and reduction of new and existing hypertrophic and keloid scars. Epicyn™ forms a protective barrier against physical, chemical and microbial invasion of the scar. It softens, flattens and reduces redness and relieves scar-associated it...
Product HANQUYOU（trastuzumab)

HANQUYOU (trastuzumab, trade name: HERCESSI™ in the U.S., Zercepac® in Europe) was successfully launched in the U.S., China and Europe, becoming the Chinese mAb biosimilar entering the U.S., the EU and China market. It is indicated for the treatment of HER2 positive early breast cancer, metastatic bre...
Product Nimotuzumab

Nimotuzumab binds with intermediate affinity and high specificity to the extracellular domain of EGFR and blocks the binding of the EGF to its receptor and inhibits tumor cell growth. The molecule induces cell lysis through ADCC mechanism. Nimotuzumab provides vaccinal effect that induce memory T-cell ...
Product Lead Discovery and design

Abzena’s antibody discovery team collaborates with you to build the foundations of a successful program and de-risk your development path. We deliver expert assessments of target molecules, immunization strategies and antibody screening cascades that inform your selection of the best candidates for develo...
Product Rituximab

Rituximab binds itself to the CD20 protein, marking them, and subsequently triggering the cells of the immune system to pick out the marked cells and kill them.The indication is for Non Hodgkin Lymphoma
Product HANDAYUAN (Adalimumab Injection)

Our first product indicated for the treatment of autoimmune diseases. HANDAYUAN (adalimumab injection) was approved by the NMPA in December 2020. It is indicated for rheumatoid arthritis, ankylosing spondylitis, plaque psoriasis, uveitis, polyarticular juvenile idiopathic arthritis, pediatric plaque ...
Product API-Epalrestat

Product name: Epalrestat

CAS NO: 82159-09-9

Appearance: Yellow to orange red crystalline powder

Specification: JP

Documentation: DMF, GMP

Application: Diabetes

Package: 25kg/drum
Product Comparability Studies for Biopharmaceuticals

We design bespoke analytical programmes that ensure that the relevant quality attributes for your drug substance or product are evaluated to support your manufacturing process changes. We select analytics referenced by the ICH Q6B to examine the product's structural features (primary, secondary and&nb...
Product TALMUSIN-0.4

Tamsulosin Hydrochloride Tablets
Product Netakimab

ONetakimab – an original humanized monoclonal antibody against IL-17. Approved in Russia for plaque psoriasis. Pending approval for ankylosing spondylitis. BIOCAD will also launch an international Phase III clinical trial with the aim of approval in EU.
Product Rituximab

Rituximab biosimilar, chimeric monoclonal antibody which specifically binds to the transmembrane antigen CD20. Indications: non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA)...
Product ENGINEERING

Csv Life Science offers Conceptual, Basic and Detail Engineering services.
Product MabionCD20

This is our most advanced in-house project. A MabThera/Rituxan (rituximab) biosimilar drug, whose efficacy and safety were clinically confirmed. It is the first such advanced drug developed in Poland. We are currently at the final stage of works aimed at marketing the drug in Europe and the United States.
Product Acarbose

White or yellowish,amorphous powder,Hygroscopic. With GMP, DMF, CEP Certificates.
Product A CDMO PARTNER FOR LIFE

FUJIFILM Diosynth Biotechnologies is an industry-leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting the biopharmaceutical industry in the development and production of biologics, vaccines and cell and gene therapies. Our focus is to combine technical leadership in process d...
Product cGMP Protein and Antibody Purification

KBI Biopharma has extensive experience developing purification processes for a wide variety of biotherapeutics, including: -Monoclonal antibodies-Bispecific antibodies -Enzymes -Fc fusion proteins -PEGylated proteins -Complex glycoproteins KBI supports 40+ annual programs ranging from FIH (First-in-Huma...
Product HANBEITAI (Bevacizumab Injection)

HANBEITAI (generic name: bevacizumab), the fourth product independently developed by Henlius, received marketing approval from the National Medical Products Administration (NMPA) in November 2021, and its commercialization in Chinese mainland is handled by the company’s in-house team. As of now, HANBEI...
Product Small-Scale Packages-RushMab

These packages are designed to offer cost-effective, time-saving solutions to meet small-scale rush needs in as fast as 8 days, with a sizable production capability for more than 5K samples.

Now adding RushMab-Gene! With only 4 days, we can have 100ug transfection-grade expr...
Product Antibody Drug Conjugates (ADC)

hen selecting AbbVie Contract Manufacturing, you are partnering with a leading developer and manufacturer focused on accelerating and mitigating risks to program timelines and on efficiently fast-tracking your program to completion. AbbVie’s mAb and ADC state-of-the-art facility and expert scientific team ...
Product Recombinant Protein Manufacturing Services

Axio BioPharma is a trusted innovator and provider of high-quality recombinant proteins designed to meet the demands of the biopharma industry. Our mission is to be your preferred partner in advancing your cutting-edge biologics.

We specialize in research-grade manufacturing of monoclonal antibo...
Product Hybridoma Sequencing

The antibody sequence is crucial for patent applications (distinguish your antibody from others), recombinant antibody expression, antibody engineering (humanization & affinity maturation), and more. Biointron offers a high-quality hybridoma sequencing service, for the sequencing of variable regions of...
Product Rituximab

Axxo gmbh offers biopharmaceutical products which includes rituximab. It belongs to monoclonal antibodies (mab)s products category. It is for rheumatoid arthritis, lymphoma, leukemia. Contact us for more information.
Product SUREmAb™

Built on the SUREtechnology Platform, SUREmAb optimizes monoclonal antibody (mAb) development and manufacturing processes, fast-tracking the path to clinic and market. • Fast-tracked for efficiency and speed, taking you from DNA transfection to GMP drug substance in 11 months • Comprehensive mAb develop...
Product Antibody / Monoclonal antibody therapeutics services

Monoclonal antibody therapeutics: We continually invest in advanced analytical instrumentation that allows us to deliver mAb analytical data with the highest degree of sensitivity, accuracy and resolution. Our experience spans recombinant monoclonal antibodies and related products such as biosimilars, ...
Product Brimonidne/Timolol Eye Drops

Contact us for more information.
Product Protein Aggregation Analysis and Characterization

Analysis and characterization of protein aggregates: The services provided by our experts include a range of protein aggregation analysis techniques that are used to detect and quantify aggregates in solution in support of formulation development, quality control, stability studies, comparability, rel...
Product Trastuzumab

Trastuzumab binds to the extracellular domain of human epidermal growth factor receptor 2 (HER2) and inhibits HER2 homodimerization, thereby preventing HER2-mediated signaling. The indication is for HER2 Triple Positive and HER2+ Gastric Cancer / Gastroesophageal Junction cancer.
Product Sterile Products Contract Manufacturing

Our main CDMO activity is the large scale manufacturing of injectable products in our internationally reputed site in Pau (France). The site is organized around 9 independent workshops, specialized in the aseptic filling under isolators of potent molecules such as anticancer cytotoxics, monoclonal ant...
Product Doxylag 100mg (Doxycycline) Caps

Doxycycline, the active ingredient of Doxylag, is an antibiotic that exhibits a wide spectrum of antimicrobial activity against both Gram-positive & Gram-negative bacteria.
Product High-Throughput Recombinant Antibody Production

Biointron's high-throughput antibody production provides the most cost-effective option for recombinant antibodies, where you may choose to deliver either supernatant or purified antibodies (ug to gram level). From gene synthesis to purified antibodies (IgG, scFv, VHH, etc.), it takes as fast as 2 weeks. A...
Product Filgrastim (g-csf)

Axxo gmbh offers biopharmaceutical products which includes filgrastim (g-csf). It belongs to recombinant human proteins products category. It is for post-cancer treatment. Contact us for more information.
Product 3BNC117 - A Novel Broad-spectrum HIV Neutralizing Antibody

3BNC117 is one of the most effective broad-spectrum HIV neutralizing antibodies. Several phase 1 and phase 2 clinical trials have been conducted in the US, showing 3BNC117 not only blocks viral replication like other AIDS drugs, but also induces immune response to HIV and HIV-infected cells. Combining 3...
Product VHH Antibody Discovery

SdAb or VHH is a promising next-generation therapeutic antibody technology for cancer immunotherapy and other applications. Biointron is a well-recognized leader in the field of single domain antibody discovery. Based on our advanced phage display technology and high-throughput antibody expression platform...
Product Protein Therapeutic Glycosylation Studies

In line with ICH Q6B, we deliver glycosylation analysis for proteins, antibodies, bispecifics including assessment of the glycosylation site, carbohydrate content and glycan structure. With a range of MS approaches, our protein characterisation scientists provide detailed glycosylation studies designed to ...

Recently Visited

Product Proteinase K 39450-01-6